Investing.com - AstraZeneca ADR reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
AstraZeneca ADR announced earnings per share of $0.94 on revenue of $6.58B. Analysts polled by Investing.com anticipated EPS of $0.5 on revenue of $6.62B.
AstraZeneca ADR shares are up 10.37% from the beginning of the year and are trading at $55.03 , down-from-52-week-high.They are under-performing the Nasdaq which is up 29.18% from the start of the year.
AstraZeneca ADR follows other major Healthcare sector earnings this month
AstraZeneca ADR's report follows an earnings beat by J&J on Tuesday, October 13, 2020, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Pfizer had beat expectations on Tuesday, October 27, 2020 with third quarter EPS of $0.72 on revenue of $12.13B, compared to forecast for EPS of $0.71 on revenue of $12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar